Applied Molecular Transport Return on Equity

Applied Molecular Transport (AMTI) currently reports a ROE of -450.4%. That is below the Healthcare sector average of 22.13%. Use the charts on this page to explore Applied Molecular Transport's ROE history and peer comparisons.

Applied Molecular Transport's ROE of -450.4% is lower than the Healthcare sector average of 22.13%. That is roughly 2135.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Applied Molecular Transport's current -450.4% should be judged against Healthcare norms (sector average: 22.13%) and against AMTI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -450.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.13%. From there, open related valuation or income-statement pages for Applied Molecular Transport, and consider following AMTI for alerts when major investors trade the stock.

Applied Molecular Transport is classified in the Healthcare sector. On ROE, it currently shows -450.4% versus a sector average near 22.13%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMTI with unrelated industries.